These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effects of pamidronate and calcitriol on the set point of the parathyroid gland in postmenopausal hemodialysis patients with secondary hyperparathyroidism. Huang CY; Zheng CM; Wu CC; Lo L; Lu KC; Chu P Nephron Clin Pract; 2012; 122(3-4):93-101. PubMed ID: 23635416 [TBL] [Abstract][Full Text] [Related]
25. Effect of calcitriol and age on recovery from hypocalcemia in hemodialysis patients. Borrego MJ; Martin-Malo A; Almaden Y; Rodriguez M; Aljama P; Felsenfeld AJ Am J Kidney Dis; 1999 Sep; 34(3):456-63. PubMed ID: 10469855 [TBL] [Abstract][Full Text] [Related]
26. In vivo assessments of calcium-regulated parathyroid hormone release in secondary hyperparathyroidism. Goodman WG; Belin TR; Salusky IB Kidney Int; 1996 Dec; 50(6):1834-44. PubMed ID: 8943464 [TBL] [Abstract][Full Text] [Related]
27. Effect of intravenous calcitriol on platelet intracellular calcium in uremic hemodialysis patients with secondary hyperparathyroidism. Lin SH; Shieh SD; Chyr SH; Lu KC; Lin YF; Diang LK; Chou TC; Ding YA Zhonghua Yi Xue Za Zhi (Taipei); 1994 Oct; 54(4):240-5. PubMed ID: 7982134 [TBL] [Abstract][Full Text] [Related]
28. The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism. Lindberg JS; Moe SM; Goodman WG; Coburn JW; Sprague SM; Liu W; Blaisdell PW; Brenner RM; Turner SA; Martin KJ Kidney Int; 2003 Jan; 63(1):248-54. PubMed ID: 12472790 [TBL] [Abstract][Full Text] [Related]
29. Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3. Ledger GA; Burritt MF; Kao PC; O'Fallon WM; Riggs BL; Khosla S J Clin Endocrinol Metab; 1994 Jul; 79(1):211-6. PubMed ID: 8027229 [TBL] [Abstract][Full Text] [Related]
30. Serum parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D3 in patients on maintenance haemodialysis. Rassoul Z; Mousa D; Rehman MA; Abdalla AH; Hawas F; Popovich W; Gaisoum M; al-Sulaiman M; Al-Khader A Am J Nephrol; 1995; 15(6):507-11. PubMed ID: 8546173 [TBL] [Abstract][Full Text] [Related]
31. Effect of intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients. Liou HH; Chiang SS; Tsai SC; Chang CC; Wu SC; Shieh SD; Huang TP Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jun; 53(6):319-24. PubMed ID: 8087705 [TBL] [Abstract][Full Text] [Related]
32. Calcitriol and the parathyroid hormone-ionized calcium curve: a comparison of methodologic approaches. Ouseph R; Leiser JD; Moe SM J Am Soc Nephrol; 1996 Mar; 7(3):497-505. PubMed ID: 8704117 [TBL] [Abstract][Full Text] [Related]
33. Estrogen replacement decreases the set point of parathyroid hormone stimulation by calcium in normal postmenopausal women. Boucher A; D'Amour P; Hamel L; Fugère P; Gascon-Barré M; Lepage R; Ste-Marie LG J Clin Endocrinol Metab; 1989 Apr; 68(4):831-6. PubMed ID: 2921312 [TBL] [Abstract][Full Text] [Related]
34. Effect of CAPD and hemodialysis on parathyroid function. Malberti F; Corradi B; Imbasciati E Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912 [TBL] [Abstract][Full Text] [Related]
36. Control of parathyroid function in patients with a short history of hemodialysis. Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904 [TBL] [Abstract][Full Text] [Related]
37. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism. Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002 [TBL] [Abstract][Full Text] [Related]
38. Parathyroid gland function in secondary hyperparathyroidism. Salusky IB; Goodman WG Pediatr Nephrol; 1996 Jun; 10(3):359-63. PubMed ID: 8792406 [TBL] [Abstract][Full Text] [Related]
39. Multicenter clinical trial of 22-oxa-1,25-dihydroxyvitamin D3 for chronic dialysis patients. Yasuda M; Akiba T; Nihei H Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S108-11. PubMed ID: 12612965 [TBL] [Abstract][Full Text] [Related]
40. High-dose oral calcitriol and zero calcium peritoneal solutions in CAPD patients with refractory secondary hyperparathyroidism. Malberti F; Scanziani R; Corradi B; Dozio B; Bonforte G; Imbasciati E; Surian M Nephrol Dial Transplant; 1994; 9(12):1813-5. PubMed ID: 7708273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]